Advancing Genomics for Drug Development and Safety Evaluation

Advancing Genomics for Drug Development and Safety Evaluation

Saved in:

Bibliographic Details
Main Authors:	Zhichao Liu, Joshua Xu, Zhining Wen
Format:	Article
Language:	English
Published:	Wiley 2018-01-01
Series:	International Journal of Genomics
Online Access:	http://dx.doi.org/10.1155/2018/3126820
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Advances in the Drug Development and Quality Evaluation Principles of Oncolytic Herpes Simplex Virus
by: Basma Eid Abdullah Ghorab, et al.
Published: (2025-04-01)

Comparative Evaluation of the Efficacy and Safety of Primary Trabeculectomy and Drug Therapy in Patients with Advanced Open-angle Glaucoma
by: S. U. Kasumov, et al.
Published: (2025-06-01)

Recent Advances in Omics, Computational Models, and Advanced Screening Methods for Drug Safety and Efficacy
by: Ahrum Son, et al.
Published: (2024-11-01)

EVALUATION OF SAFETY OF DRUG THERAPY IN CLINICAL PRACTICE
by: M. N. Kostyleva, et al.
Published: (2015-03-01)

Advanced In Vitro Models for Preclinical Drug Safety: Recent Progress and Prospects
by: Dileep G. Nair, et al.
Published: (2024-12-01)

Artificial intelligence in pharmacovigilance: advancing drug safety monitoring and regulatory integration
by: Ankit Nagar, et al.
Published: (2025-07-01)

Advancing drug development in myelodysplastic syndromes
by: Alain Mina, et al.
Published: (2025-03-01)

Parent Engagement in Youth Drug Prevention in Chinese Families: Advancement in Program Development and Evaluation
by: Sandra K. M. Tsang
Published: (2011-01-01)

Biomaterial-based drug delivery: evaluating the safety profiles of liposomal Vyxeos
by: Zhicheng Liu, et al.
Published: (2025-12-01)

Advancing the Integration of Digital Health Technologies in the Drug Development Ecosystem
by: Sakshi Sardar, et al.
Published: (2025-07-01)

ToxBERT: an explainable AI framework for enhancing prediction of adverse drug reactions and structural insights
by: Yujie He, et al.
Published: (2025-08-01)

The problem in the evaluation of the efficacy and safety of nonsteroidal anti-inflammatory drugs
by: N. V. Chichasova
Published: (2016-06-01)

Developing an advanced safety device for bridge-type cranes
by: A. N. Nazarov, et al.
Published: (2025-01-01)

Advances in mitochondrial autophagy regulation of bone remodeling and the role of drug intervention
by: WANG Yiyuan, et al.
Published: (2024-11-01)

Advances in gasdermin activation, regulation, and targeted drug development
by: Tai Luo, et al.
Published: (2025-06-01)

Pantoprazole – safety in drug-drug interaction
by: E. V. Shikh, et al.
Published: (2012-09-01)

The safety and effectiveness of sintilimab versus camrelizumab, both plus targeted drugs, in advanced hepatocellular carcinoma
by: Chenglong Zhao, et al.
Published: (2025-06-01)

DRUGS SAFETY IN CHILDREN
by: Sadhna laljee, et al.
Published: (2024-09-01)

Monitoring of drug safety
by: B. K. Romanov, et al.
Published: (2022-06-01)

A Review on New Frontiers in Drug-Drug Interaction Predictions and Safety Evaluations with In Vitro Cellular Models
by: Lara Marques, et al.
Published: (2025-06-01)

Advancing Transportation Equity and Safety Through Autonomous Vehicles
by: Johnathon P. Ehsani, et al.
Published: (2024-12-01)

Editorial: Safety consideration in the development of anti-tumor monoclonal antibodies during drug development
by: Tao Wang, et al.
Published: (2025-07-01)

Development and evaluation of drugs : from laboratory through licensure to market /
by: Lee, Chi-Jen
Published: (2003)

Editorial: Advances in mitochondria-targeting in drug development for common disorders
by: Mundla Srilatha, et al.
Published: (2025-01-01)

Using Artificial Intelligence to Advance the Research and Development of Orphan Drugs
by: Carla Irissarry, et al.
Published: (2024-09-01)

Comprehensive genomic analysis and evaluation of in vivo and in vitro safety of Heyndrickxia coagulans BC99
by: Ying Wu, et al.
Published: (2024-11-01)

Food safety considerations in the advancement of cultured meat: Evaluating novel ingredients
by: Sawali Navare, et al.
Published: (2025-06-01)

Exploring advanced genomic and immunoinformatics techniques for identifying drug and vaccine targets against SARS-CoV-2
by: Syed Luqman Ali, et al.
Published: (2024-12-01)

Advancement in nanobubble technology: enhancing drug and nutraceutical delivery with focus on bioavailability, targeted therapy, safety, and sustainability
by: Farhang Hameed Awlqadr, et al.
Published: (2025-06-01)

Advanced LC-MS/MS method for selective quantification of nitrosamine impurities in Risperidone: Enhancing drug safety
by: Hitesh Thumbar, et al.
Published: (2025-08-01)

Passive Safety Systems in Advanced PWRs
by: Xu Cheng, et al.
Published: (2009-01-01)

Self-authenticating genomic materials in Escherichia coli via advanced genome signatures
by: Zhaoguan Wang, et al.
Published: (2025-05-01)

Filling the gap in CNS drug development: evaluation of the role of drug repurposing
by: A. Caban, et al.
Published: (2017-01-01)

International Drug Safety Monitoring
by: A. S. Kazakov, et al.
Published: (2019-09-01)

ISSUES OF FETUS DRUG SAFETY
by: A.V. Ostrovskaya, et al.
Published: (2010-02-01)

Drug Safety Monitoring Information
by: E. V. Shubnikova, et al.
Published: (2021-07-01)

Advances in Vehicle Safety and Crash Avoidance Technologies
by: Chuan Xu, et al.
Published: (2025-05-01)

Correction: Advancement in nanobubble technology: enhancing drug and nutraceutical delivery with focus on bioavailability, targeted therapy, safety, and sustainability
by: Frontiers Production Office
Published: (2025-07-01)

Real world study on efficacy and safety of surufatinib in advanced solid tumors evaluation
by: Hui-Ping Yan, et al.
Published: (2025-05-01)

Advances research in porcine enteric coronavirus therapies and antiviral drugs
by: Jixiang Liang, et al.
Published: (2024-12-01)